CITIGROUP INC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2023$1,074,416
+767340.0%
651,161
+651061.0%
0.00%
Q4 2022$140
-86.0%
100
-73.6%
0.00%
Q2 2022$1,000
-80.0%
379
-79.4%
0.00%
Q1 2022$5,000
-92.2%
1,837
-82.6%
0.00%
Q4 2021$64,000
+88.2%
10,574
+105.1%
0.00%
Q3 2021$34,000
+30.8%
5,155
+32.8%
0.00%
Q2 2021$26,000
-87.2%
3,883
-82.2%
0.00%
Q1 2021$203,000
-52.8%
21,873
-8.6%
0.00%
Q4 2020$430,00023,928
+199300.0%
0.00%
Q3 2020$0120.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders